Latest ResoTher Pharma News & Updates

See the latest news and media coverage for ResoTher Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
ResoTher Pharma

Clinical-stage biotech developing resolution therapies for cardiovascular inflammation

resotherpharma.com
Headquarters
Holte, Denmark
Founded year
2016
Company type
Private company
Number of employees
2–20

Last updated

Latest news about ResoTher Pharma

In short: ResoTher Pharma initiated a Phase 2a clinical trial for RTP-026, secured a €2.5 million EIC grant, and synthesized new anti-inflammatory agonists.

Company announcements

ResoTher Pharma

CFO chooses ResoTher Pharma

CFO of two companies selects ResoTher due to exciting funding, biotech passion, and Phase 2 trial launch. Article in Danish.

ResoTher Pharma

ResoTher Pharma appoints Anders Kronborg as CEO

The appointment takes effect February 1, 2023. He succeeds Lone Veng, who led since 2017 and advanced RTP-026 into clinical development.

Unlock all announcements with a

Media coverage

Økonomisk Ugebrev

ResoTher Pharma works with peptide-based molecules

ResoTher Pharma is a Danish biotech company that develops new therapeutic agents based on a unique approach to inflammatory treatment. ResoTher works with peptide-based molecules that...

Track future articles with a

Never miss news about ResoTher Pharma

Track ResoTher Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

ResoTher Pharma competitors & trending companies

Browse news for competitors to ResoTher Pharma and other trending companies.